SARS-CoV-2 Neutralizing Antibody Responses Are More Robust in Patients with Severe Disease
P. Wang, L. Liu, M. S. Nair, M. T. Yin, Y. Luo, Q. Wang, T. Yuan, K. Mori, A. G. Solis, M. Yamashita, L. J. Purpura, J. C. Laracy, J. Yu, J. Sodroski, Y. Huang, D. D. Ho
This study finds that patients with severe SARS-CoV-2 disease have higher antibody titers against viral proteins and neutralization capabilities compared to less severe cases.
Emerging Microbes & Infections · Sep 25, 2020Peer-reviewedMicrobiology